Anti-Parkinson Drugs MCQs
1. Parkinson’s disease is associated with a significant depletion of which neurotransmitter?
2. Which is the primary treatment for Parkinson’s disease?
3. Which percentage of patients with Parkinson’s disease respond favorably to levodopa?
4. Which adverse effect of levodopa toxicity is the most disabling?
b. Nausea and vomiting.
c. Orthostatic hypotension.
d. Abnormal involuntary movements (AIMs).
5. Which drug inhibits the decarboxylation of levodopa in the periphery so more levodopa can reach the CNS?
6. Which non-Parkinson’s movement disorder results from a genetic error on a specific gene?
a. Wilson’s disease.
b. Dystonic syndromes.
c. Tourette’s syndrome.
d. Huntington’s disease.
7. Parkinson’s disease patients should schedule their dental treatment within
a. 1 to 1.5 hours of taking levodopa.
b. 2 to 4 hours of taking levodopa.
c. 5 to 6.5 hours of taking levodopa.
d. 7 to 9 hours of taking levodopa.
8. Which direct dopamine receptor agonist is approved to treat restless leg syndrome (RLS)?
9. Levodopa-related hypertension is most severe in the company of which contributor?
a. Age-related heart disease.
b. Decarboxylase inhibitors.
c. Peripheral metabolism of levodopa to dopamine.
d. Drug interaction with nonselective monoamine oxidase (MAO) inhibitors.